Search research articles
Contact Us
Filters
Showing results (351-360 of 519) with videos related to
Page
of 52
Sort By:
Journal of the National Cancer Institute. Monographs
|
September 1, 2014
Medical history, lifestyle, family history, and occupational risk factors for lymphoplasmacytic lymphoma/Waldenström's macroglobulinemia: the InterLymph Non-Hodgkin Lymphoma Subtypes Project
Claire M Vajdic, Ola Landgren, Mary L McMaster, et al.
Blood Cancer Discovery
|
September 4, 2025
Timing genomic antigen loss in multiple myeloma treated with T-cell redirecting immunotherapies
Marios Papadimitriou, Sungwoo Ahn, Benjamin T Diamond, et al.
Blood Advances
|
January 4, 2018
Bone disease in monoclonal gammopathy of undetermined significance: results from a screened population-based study
Sigrun Thorsteinsdottir, Sigrun H Lund, Ebba K Lindqvist, et al.
The American Journal of Gastroenterology
|
February 11, 2015
Trends and racial/ethnic disparities in gluten-sensitive problems in the United States: findings from the National Health and Nutrition Examination Surveys from 1988 to 2012
Rok Seon Choung, Ivo C Ditah, Ashley M Nadeau, et al.
Hemasphere
|
July 17, 2025
Current and future role of carfilzomib-based quadruplet combinations as therapy for newly diagnosed multiple myeloma
Ola Landgren, Noa Biran, Elizabeth K O'Donnell, et al.
Leukemia & Lymphoma
|
August 10, 2017
Host-related immunodeficiency in the development of multiple myeloma
Talib Dosani, Sham Mailankody, Neha Korde, et al.
Blood
|
April 28, 2010
Obesity is associated with an increased risk of monoclonal gammopathy of undetermined significance among black and white women
Ola Landgren, S Vincent Rajkumar, Ruth M Pfeiffer, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
May 4, 2011
Treatment-related risk factors for transformation to acute myeloid leukemia and myelodysplastic syndromes in myeloproliferative neoplasms
Magnus Björkholm, Asa R Derolf, Malin Hultcrantz, et al.
Elife
|
September 2, 2015
Paradoxical resistance of multiple myeloma to proteasome inhibitors by decreased levels of 19S proteasomal subunits
Diego Acosta-Alvear, Min Y Cho, Thomas Wild, et al.
The American Journal of Surgical Pathology
|
March 3, 2020
Genetic Basis of Extramedullary Plasmablastic Transformation of Multiple Myeloma
Ying Liu, Fatima Jelloul, Yanming Zhang, et al.
Page
of 52
Search research articles
Search
Showing results (351-360 of 519) with videos related to
Sort By:
Page
of 52
Journal of the National Cancer Institute. Monographs
|
September 1, 2014
Medical history, lifestyle, family history, and occupational risk factors for lymphoplasmacytic lymphoma/Waldenström's macroglobulinemia: the InterLymph Non-Hodgkin Lymphoma Subtypes Project
Claire M Vajdic, Ola Landgren, Mary L McMaster, et al.
Blood Cancer Discovery
|
September 4, 2025
Timing genomic antigen loss in multiple myeloma treated with T-cell redirecting immunotherapies
Marios Papadimitriou, Sungwoo Ahn, Benjamin T Diamond, et al.
Blood Advances
|
January 4, 2018
Bone disease in monoclonal gammopathy of undetermined significance: results from a screened population-based study
Sigrun Thorsteinsdottir, Sigrun H Lund, Ebba K Lindqvist, et al.
The American Journal of Gastroenterology
|
February 11, 2015
Trends and racial/ethnic disparities in gluten-sensitive problems in the United States: findings from the National Health and Nutrition Examination Surveys from 1988 to 2012
Rok Seon Choung, Ivo C Ditah, Ashley M Nadeau, et al.
Hemasphere
|
July 17, 2025
Current and future role of carfilzomib-based quadruplet combinations as therapy for newly diagnosed multiple myeloma
Ola Landgren, Noa Biran, Elizabeth K O'Donnell, et al.
Leukemia & Lymphoma
|
August 10, 2017
Host-related immunodeficiency in the development of multiple myeloma
Talib Dosani, Sham Mailankody, Neha Korde, et al.
Blood
|
April 28, 2010
Obesity is associated with an increased risk of monoclonal gammopathy of undetermined significance among black and white women
Ola Landgren, S Vincent Rajkumar, Ruth M Pfeiffer, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
May 4, 2011
Treatment-related risk factors for transformation to acute myeloid leukemia and myelodysplastic syndromes in myeloproliferative neoplasms
Magnus Björkholm, Asa R Derolf, Malin Hultcrantz, et al.
Elife
|
September 2, 2015
Paradoxical resistance of multiple myeloma to proteasome inhibitors by decreased levels of 19S proteasomal subunits
Diego Acosta-Alvear, Min Y Cho, Thomas Wild, et al.
The American Journal of Surgical Pathology
|
March 3, 2020
Genetic Basis of Extramedullary Plasmablastic Transformation of Multiple Myeloma
Ying Liu, Fatima Jelloul, Yanming Zhang, et al.
Page
of 52